Switch to:

CRISPR Therapeutics AG EPS (Basic)

: $0.60 (TTM As of Jun. 2020)
View and export this data going back to 2016. Start your Free Trial

CRISPR Therapeutics AG's basic earnings per share (Basic EPS) for the three months ended in Jun. 2020 was $-1.30. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jun. 2020 was $0.60.

CRISPR Therapeutics AG's EPS (Diluted) for the three months ended in Jun. 2020 was $-1.30. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2020 was $0.46.

CRISPR Therapeutics AG's EPS without NRI for the three months ended in Jun. 2020 was $-1.30. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2020 was 0.46.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 6 years, CRISPR Therapeutics AG's highest 3-Year average EPS without NRI Growth Rate was -39.80% per year. The lowest was -94.60% per year. And the median was -67.20% per year.


CRISPR Therapeutics AG EPS (Basic) Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

CRISPR Therapeutics AG Annual Data
Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
EPS (Basic) Premium Member Only -0.88 -1.89 -1.71 -3.44 1.23

CRISPR Therapeutics AG Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
EPS (Basic) Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.01 2.52 0.53 -1.15 -1.30

CRISPR Therapeutics AG EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

CRISPR Therapeutics AG's Basic EPS for the fiscal year that ended in Dec. 2019 is calculated as

Basic EPS (A: Dec. 2019 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(66.858-0)/56.933
=1.17

CRISPR Therapeutics AG's Basic EPS for the quarter that ended in Jun. 2020 is calculated as

Basic EPS (Q: Jun. 2020 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-79.656-0)/61.421
=-1.30

EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2020 was 2.52 (Sep. 2019 ) + 0.53 (Dec. 2019 ) + -1.15 (Mar. 2020 ) + -1.3 (Jun. 2020 ) = $0.60

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


CRISPR Therapeutics AG  (NAS:CRSP) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


CRISPR Therapeutics AG EPS (Basic) Related Terms


CRISPR Therapeutics AG EPS (Basic) Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)